-
Prognostic relevance of limit of quantification as low-level cutoff for flow cytometry-based measurable residual disease assessment in acute myeloid leukemia
Haaksma, L. H., Palmieri, R., Reuvekamp, T., Tettero, J. M., Ngai, L. L., Bachas, C., Kelder, A., Scholten, W. J., Gradowska, P., Arena, V., João Simione, A., Maurillo, L., Venditti, A., Löwenberg, B., Ossenkoppele, G. J., de Leeuw, D. C., Ikoma-Colturato, M. R. V., Buccisano, F. & Cloos, J., 10 Dec 2025, (E-pub ahead of print) In: Leukemia.Research output: Contribution to journal › Article › Academic › peer-review
-
Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial
Mocking, T. R., Haaksma, L. H., Reuvekamp, T., Kelder, A., Scholten, W. J., Ngai, L. L., Breems, D. A., Fischer, T., Gjertsen, B. T., Griškevičius, L., Juliusson, G., Maertens, J. A., Manz, M. G., Pabst, T., Passweg, J. R., Porkka, K., Valk, P. J. M., Gradowska, P., Löwenberg, B. & de Leeuw, D. C. & 5 others, , Oct 2025, In: Leukemia. 39, 10, p. 2559-2562 4 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Towards optimal tailored therapy: Improving Measurable Residual Disease and Leukemic Stem Cell detection in Acute Myeloid Leukemia
Ngai, L. L., 4 Sept 2025, 330 p.Research output: PhD thesis › Research HvA, graduation HvA (not in use)
- All publications
